Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kropf PL"'
Autor:
Moreb JS; Hematology, Transplantation and Cellular Therapy, Novant Health Cancer Institute, Winston-Salem, NC, USA. Electronic address: jsmoreb@novanthealth.org., Lantos L; Transplantation and Cellular Therapy Program, Novant Health Cancer Institute, Charlotte, NC, USA., Chen F; Hematology, Transplantation and Cellular Therapy, Novant Health Cancer Institute, Winston-Salem, NC, USA., Elliott K; Hematology, Transplantation and Cellular Therapy, Novant Health Cancer Institute, Winston-Salem, NC, USA., Dugan J; Hematology, Transplantation and Cellular Therapy, Novant Health Cancer Institute, Winston-Salem, NC, USA., Skarbnik AP; Transplantation and Cellular Therapy Program, Novant Health Cancer Institute, Charlotte, NC, USA., Kropf PL; Transplantation and Cellular Therapy Program, Novant Health Cancer Institute, Charlotte, NC, USA., Ward K; Transplantation and Cellular Therapy Program, Novant Health Cancer Institute, Charlotte, NC, USA.
Publikováno v:
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2023 Dec; Vol. 62 (6), pp. 103787. Date of Electronic Publication: 2023 Aug 29.
Autor:
Fenaux P; Hôpital Saint-Louis, Paris, France., Gobbi M; Ospedale Policlinico San Martino, Genova, Italy., Kropf PL; Novant Health Cancer Institute - Elizabeth, Charlotte, NC., Issa JJ; Coriell Institute for Medical Research, Camden, NJ., Roboz GJ; Weill Cornell Medicine, New York, NY., Mayer J; Fakultní Nemocnice, Brno, Česká Republika., Krauter J; Städtisches Klinikum Braunschweig gGmbH, Braunschweig, Germany., Robak T; Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland., Kantarjian H; The University of Texas MD Anderson Cancer Center, Houston, TX., Novak J; Univerzita Karlova, Praha, Česká Republika., Jedrzejczak WW; Samodzielny Publiczny Centralny Szpital Kliniczny, Warszawa, Poland., Thomas X; Hôpital Lyon Sud, Pierre Bénite, France., Ojeda-Uribe M; GHR Mulhouse Sud-Alsace, Mulhouse, France., Miyazaki Y; Nagasaki University Hospital, Nagasaki, Japan., Min YH; Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea., Yeh SP; China Medical University Hospital, Taichung City, Taiwan., Brandwein J; University of Alberta Hospital, Edmonton, Canada., Gercheva-Kyuchukova L; Hospital 'St. Marina' EAD, Varna, Bulgaria., Demeter J; Semmelweis Egyetem, Budapest, Hungary., Griffiths E; Roswell Park Comprehensive Cancer Institute, Buffalo, NY., Yee K; Princess Margaret Cancer Centre, Toronto, ON, Canada., Döhner K; Ulm University Hospital, Ulm, Germany., Hao Y; Astex Pharmaceuticals Inc, Pleasanton, CA., Keer H; Astex Pharmaceuticals Inc, Pleasanton, CA., Azab M; Astex Pharmaceuticals Inc, Pleasanton, CA., Döhner H; Ulm University Hospital, Ulm, Germany.
Publikováno v:
Blood advances [Blood Adv] 2023 Sep 12; Vol. 7 (17), pp. 5027-5037.
Autor:
Roboz GJ; Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York., Kantarjian HM; The University of Texas MD Anderson Cancer Center, Houston, Texas., Yee KWL; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Kropf PL; Fox Chase Cancer Center, Philadelphia, Pennsylvania., O'Connell CL; Keck School of Medicine, University of Southern California, Los Angeles, California., Griffiths EA; Roswell Park Cancer Institute, Buffalo, New York., Stock W; University of Chicago, Chicago, Illinois., Daver NG; The University of Texas MD Anderson Cancer Center, Houston, Texas., Jabbour E; The University of Texas MD Anderson Cancer Center, Houston, Texas., Ritchie EK; Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York., Walsh KJ; Ohio State University, Columbus, Ohio., Rizzieri D; Duke University Medical Center, Durham, North Carolina., Lunin SD; Florida Cancer Specialist and Research Institute, Fort Myers, Florida., Curio T; Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York., Chung W; Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, Pennsylvania., Hao Y; Astex Pharmaceuticals, Pleasanton, California., Lowder JN; Astex Pharmaceuticals, Pleasanton, California., Azab M; Astex Pharmaceuticals, Pleasanton, California., Issa JJ; Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, Pennsylvania.
Publikováno v:
Cancer [Cancer] 2018 Jan 15; Vol. 124 (2), pp. 325-334. Date of Electronic Publication: 2017 Dec 06.
Autor:
Kantarjian HM; University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX, USA. Electronic address: hkantarjian@mdanderson.org., Roboz GJ; Weill Cornell Medicine, Division of Hematology and Oncology, the New York Presbyterian Hospital, New York, NY, USA., Kropf PL; Fox Chase Cancer Center, Jeanes Hospital, Philadelphia, PA, USA., Yee KWL; Princess Margaret Cancer Centre, Toronto, ON, Canada., O'Connell CL; USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Tibes R; Mayo Clinic Arizona, Scottsdale, AZ, USA; Department of Internal Medicine II/Division of Hematology and Medical Oncology, University Medical Center, Würzburg, Germany., Walsh KJ; Ohio State University, James Cancer Hospital, Wexner Medical Center, Columbus, OH, USA., Podoltsev NA; Yale University School of Medicine, Hematology Division, New Haven, CT, USA., Griffiths EA; Roswell Park Cancer Institute, Buffalo, NY, USA., Jabbour E; University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX, USA., Garcia-Manero G; University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX, USA., Rizzieri D; Duke University Medical Center, Durham, NC, USA., Stock W; University of Chicago, MC2115, Chicago, IL, USA., Savona MR; Vanderbilt University Medical Center, Division of Hematology and Oncology, Nashville, TN, USA., Rosenblat TL; New York-Presbyterian/Columbia University Medical Center, New York, NY, USA., Berdeja JG; Sarah Cannon Research Institute, Nashville, TN, USA., Ravandi F; University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX, USA., Rock EP; Astex Pharmaceuticals, Pleasanton, CA, USA., Hao Y; Astex Pharmaceuticals, Pleasanton, CA, USA., Azab M; Astex Pharmaceuticals, Pleasanton, CA, USA., Issa JJ; Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia PA, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2017 Oct; Vol. 18 (10), pp. 1317-1326. Date of Electronic Publication: 2017 Aug 24.
Autor:
Zaorsky NG; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address: nicholaszaorsky@gmail.com., Williams GR; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Barta SK; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Esnaola NF; Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Kropf PL; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Hayes SB; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Meyer JE; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address: joshua.meyer@fccc.edu.
Publikováno v:
Cancer treatment reviews [Cancer Treat Rev] 2017 Feb; Vol. 53, pp. 47-52. Date of Electronic Publication: 2016 Dec 22.
Autor:
Hossain NM; Hematology/Medical Oncology, Fox Chase Cancer Center/Temple University Hospital, Philadelphia, PA. Electronic address: nasheed.hossain@fccc.edu., Klumpp T; Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA., Ulicny J; Bone Marrow Transplant Program, Temple University Hospital/Fox Chase Cancer Center, Philadelphia, PA., Garner M; Bone Marrow Transplant Program, Temple University Hospital/Fox Chase Cancer Center, Philadelphia, PA., Kropf PL; Bone Marrow Transplant Program, Temple University Hospital/Fox Chase Cancer Center, Philadelphia, PA., Mangan KF; Bone Marrow Transplant Program, Temple University Hospital/Fox Chase Cancer Center, Philadelphia, PA., Barta SK; Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA., Fung HC; Bone Marrow Transplant Program, Temple University Hospital/Fox Chase Cancer Center, Philadelphia, PA., Martin ME; Bone Marrow Transplant Program, Temple University Hospital/Fox Chase Cancer Center, Philadelphia, PA.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2016 Feb; Vol. 16 (2), pp. 111-5. Date of Electronic Publication: 2015 Nov 03.
Publikováno v:
Leukemia [Leukemia] 2010 Mar; Vol. 24 (3), pp. 663-5. Date of Electronic Publication: 2009 Dec 24.
Publikováno v:
Leukemia [Leukemia] 2009 Oct; Vol. 23 (10), pp. 1933-5. Date of Electronic Publication: 2009 Jun 04.